| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6178174 | European Urology | 2013 | 9 Pages |
Abstract
ENE is an independent predictor of both cancer recurrence and cancer-specific mortality in RC patients with LNM. Knowledge of ENE status could help with patient counseling, clinical decision making regarding inclusion in clinical trials of adjuvant therapy, and tailored follow-up scheduling after RC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Harun Fajkovic, Eugene K. Cha, Claudio Jeldres, Brian D. Robinson, Michael Rink, Evanguelos Xylinas, Thomas F. Chromecki, Eckart Breinl, Robert S. Svatek, Gerhard Donner, Scott T. Tagawa, Derya Tilki, Patrick J. Bastian, Pierre I. Karakiewicz,